Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation

Therapeutic Drug Monitoring

Volumn 36, Issue 2, 2014, Pages 136-140

  Oellerich, Michael ^a   Schütz, Ekkehard ^b   Kanzow, Philipp ^a   Schmitz, Jessica ^a,b   Beck, Julia ^b   Kollmar, Otto ^a   Streit, Frank ^a   Walson, Philip D ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Chronix Biomedical   (Germany)

Author keywords

Graft injury; Graft derived cell free DNA; Liver transplantation; Tacrolimus TDM

Indexed keywords

BIOLOGICAL MARKER; GRAFT DERIVED CELL FREE DNA; MARKER; TACROLIMUS; UNCLASSIFIED DRUG; DNA; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEPATITIS C VIRUS; HUMAN; LIQUID CHROMATOGRAPHY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY; BLOOD; GRAFT REJECTION; PATIENT; PROCEDURES;

ADULT; AGED; BIOLOGICAL MARKERS; DNA; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENTS; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 84897089633     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000044     Document Type: Article

References (19)

1. Robles Piedras AL, De la O Arciniega M, Reynoso Vázquez J. Clinical pharmacology and therapeutic drug monitoring of immunosuppressive agents. In: Rath Thomas, ed. Current Issues and Future Direction in Kidney Transplantation. New York, NY: InTech; 2013:309-342
2. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43: 623-653
3. Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference. Ther Drug Monit. 2009;31:139-152
4. Rodriquez-Peralvarez M, Germani G, Darius T, et al. Tacrolimus trough levels, rejection and renal impairment in liver transplantation: A systematic review and meta-analysis. Am J Transplant. 2012;12:2797-2814
5. Venkataramanan R, Shaw LM, Sarkozi L, et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol. 2001;41:542-551
6. Kershner RP, Fitzsimmons WE. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation. 1996;62:920-926
7. De Simone P, Nevens F, De Carlis L, et al. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial. Am J Transplant. 2012;12: 3008-3020
8. Fukudo M, Yano I, Masuda S, et al. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients. Clin Pharmacol Ther. 2005;78:168-181
9. Rodriquez-Peralvarez M, Germani G, Papastergiou V, et al. Early tacrolimus exposure after liver transplantation: Relationship with moderate/ severe acute rejection and long-Term outcome, J Hepatol. 2013;58: 262-270
10. Rodriquez-Peralvarez M, Germani G, Darius T, et al. Tacrolimus exposure after liver transplantation in randomized controlled trials: Too much for too long. Am J Transplant. 2013;13:1371-1372
11. Snyder TM, Khush KK, Valantine HA, et al. Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A. 2011; 108:6229-6234
12. Beck J, Bierau S, Balzer S, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem. 2013;59: 1732-1741
13. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatographytandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem. 2002;48:955-958
14. Hilgers RA. Distribution-free confidence bounds for ROC curves. Methods Inf Med. 1991;30:96-101
15. Parzen E. On the estimation of a probability density and the mode. Ann Math Stat. 1962;33:1065-1076
16. Rosenblatt M. Remarks on some nonparametric estimates of a density function. Ann Math Stat. 1956;37:832-837
17. Huang Z, Hua D, Hu Y, et al. Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma. Pathol Oncol Res. 2012;18:271-276
18. Schütz E, Akbari MR, Beck J, et al. Quantifying copy number variations in cell-free DNA for potential clinical utility from a large prostate cancer cohort. J Clin Oncol. 2013;31. suppl. abstr 5072
19. Beck J, Schütz E, Urnovitz HB, et al. Cell-free DNA copy number variations as a marker for breast cancer in a large study. J Clin Oncol. 2013;31. suppl. abstr 11013.